Kilo Diabetes & Vascular Research Foundation
Historical collection: May 2019 · Rating details mostly from 2017. Source & context
What this organization describes
Working together to find a cure
Mission and tagline reproduced from the source record.
Three perspectives. One record.
out of 100
out of 100
out of 100
These are the dataset’s historical numeric fields, not a current rating or a new DonorAPI.com assessment. Read the score context ↗
Revenue, expenses, and composition
Program expenses
$265,614.30 recorded amountFundraising expenses
$332.85 recorded amountAdministrative expenses
$66,237.15 recorded amount- Fundraising efficiency
- $0.01 spent per $1 raised in donations, as defined in the source.
Expense shares are displayed as percentages. Component amounts in this collection match total expenses multiplied by the source ratios; rounding can leave a small difference from the total. The source does not supply a row-specific fiscal year. Field definitions ↗
The leadership information supplied
- Recorded leader
- Charles Kilo
- Recorded compensation
- $120,000.00
- Recorded compensation percentage
- 36.05%
These fields do not establish the current officeholder or current compensation. The metadata does not specify the denominator of the leader compensation percentage. Read with context ↗
Inspect all 23 original source fields
Exact source strings are retained below, including numeric precision. A blank value is marked as not reported; zero remains zero.
| Source field | Original source value |
|---|---|
ascoreAccountability & transparency score | 67.0 |
categoryCategory | Health |
descriptionMission & description | In 1972 in order to fund dedicated and ongoing research on diabetes and related vascular diseases through private sources, St. Louis physician researchers, Drs. Charles Kilo and Joseph R. Williamson founded the Kilo Diabetes & Vascular Research Foundation. The overall research objective is to understand how diabetes affects the body and to develop medications and interventions to prevent vascular damage and diabetes-induced complications of blindness, heart attacks, strokes, nerve damage and kidney failure. This research has important implications for non-diabetics as well since we have discovered great similarities between the vascular damage caused by diabetes and damage to arteries and blood vessels that leads to heart attacks and strokes in non-diabetics. |
einEIN | 23-7152540 |
tot_expTotal expenses | 332850.0 |
admin_exp_pAdministrative expense fraction | 0.19899999999999998 |
fund_effFundraising efficiency ($ per $1 raised) | 0.01 |
fund_exp_pFundraising expense fraction | 0.001 |
program_exp_pProgram expense fraction | 0.7979999999999999 |
fscoreFinancial score | 86.01 |
leaderRecorded leader | Charles Kilo |
leader_compRecorded leader compensation | 120000.0 |
leader_comp_pRecorded leader compensation fraction | 0.3605 |
mottoTagline | Working together to find a cure |
nameCharity name | Kilo Diabetes & Vascular Research Foundation |
tot_revTotal revenue | 655297.0 |
scoreOverall score | 74.65 |
stateState code | MO |
subcategorySubcategory | Diseases, Disorders, and Disciplines |
sizeSource size label | small |
program_expProgram expenses | 265614.3 |
fund_expFundraising expenses | 332.85 |
admin_expAdministrative expenses | 66237.15 |
Source: Charity Navigator Scores Expenses Dataset, version 1, attributed to katyjqian on Kaggle. Collection: May 2019; rating details mostly from 2017. Read attribution, scope, and reuse notes.